Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation

NCT02283294 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Transient Ischemic Attack
Stroke
Atrial Fibrillation

Interventions

DRUG: Apixaban
DRUG: Warfarin

Sponsor

University of South Florida

Collaborators

[object Object]